Would be an act of extremely bad faith to conduct a capital raising while sitting on a slew of bad assays. Good way to alienate new shareholders from day one.
The stock is obviously in the midst of a nasty trend reversal triggered by the raise. I suppose all we can do is wait for negative sentiment to wash through and pick up some cheap shares and position ourselves for the inevitable relief rally.
Would be an act of extremely bad faith to conduct a capital...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
